<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is a common <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> associated with major morbidity and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Atrial enlargement, remodeling, and <z:mp ids='MP_0003045'>fibrosis</z:mp> are key to initiation and perpetuation of AF </plain></SENT>
<SENT sid="2" pm="."><plain>Therapy for AF is directed at symptom control via rate or rhythm control, as well as prevention of <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In the recent past multiple alternatives, including pharmacological and non-pharmacological, have emerged as possible therapies for AF </plain></SENT>
<SENT sid="4" pm="."><plain>In this review, we intend to summarize the most important advances in AF therapy in recent years </plain></SENT>
</text></document>